RxDoctor Payments Data

Donna Hayes, DPM

Podiatrist · Chicago, ILNPI 1225045651

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (49.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Elite Orthopedics, LLC at 49.8% of the total. Reporting peaked in 2019 at $3,371 and has fallen 99.6% since, to $15 in 2025.

$6,344in general payments, 2019–2025

Across 137 payments — averaging $46.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elite Orthopedics, LLC$3K
  • Treace Medical Concepts, Inc.$604
  • Lilly USA, LLC$290
  • AbbVie$276
  • Pfizer$250
  • Novo Nordisk$247
  • plus $2K from 30 others

What the payments were for

  • Travel & lodging$5639%
  • Food & beverage$2,62441%
  • Education$3,15750%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,344 in reported general payments places this provider in the 85th percentile of 409 podiatrist providers in Illinois.

See all podiatrist providers in Illinois

Medicare billing

Part B allowed, 2024
$146,083
Medicare patients
225
Services billed
2,493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole37$1,519
Ammonium Lactate32$963
Cefadroxil47$448
Mupirocin39$420
Clindamycin Hcl21$294
Triamcinolone Acetonide29$228
Doxycycline Hyclate11$171
Cephalexin16$134
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$120

Paid to pharmacies, not to this prescriber.

Other podiatrist in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →